Login    Join free Add to favorites    中文
Home > News > The 3rd Annual Asia Pharma R&D Innovation Conference 2019
Industry Updates New Products Supplier News Upcoming Events business web
The 3rd Annual Asia Pharma R&D Innovation Conference 2019
hits:333     Date:12/07/18

Asia Pharma R&D Innovation 2019

March 13th-14th ,2019鈭yndham Bund East Shanghai,China
 
Asia Pharma R&D Innovation 2019 is the only event that brings together senior level executives from global and regional pharma companies, biotechs, CROs, academic institutions, technology and solution provider, investors and all the way down to other industrial stakeholders to assess the latest industrial trends, R&D strategies, partnership models and technology advancements in China and Asia.

This is the largest annual pharmaceutical R&D gathering in China featuring multiple conferences, summits and seminars that cover the entire value chain of the pharma R&D. Asia Pharma R&D Innovation 2019 will show you how you can access the important markets in Asia that matters most to your R&D strategies. Our aim is to promote global and regional deal making between pharmas, biotechs and academics in China and across other Asian countries and to leverage technologies to your advantage in promising drug discovery, screening, safety, clinical trials and R&D activities in the region.
 
Key topics will cover:
• Asia鈥檚 R&D landscape from big pharma鈥檚 eyes
• How Collaboration is Driving Innovation in Research & Development ?
• Boosting China's new Drug Research and Development to Enhance Global Competitiveness
• Regulatory Data Protection, Patent Linkage and Patent Term Extension in New Drug Discovery and Development 
• Tapping into Funding and Investment Opportunities on New Drug Discovery and Development in China
• Chinese BioPharma R&D Collaboration Opportunities and Development Models Innovation in the Future
• Case study of drug R&D and Oncology Therapeutic Focus
• Excellence in services 鈥 Technology showcase
• Omics,New Biomarker Discovery and Precision Medicine Development,Novel Technologies for Drug Discovery
• Clinical Trials Innovation
• Biomarker & Real World Data Based Decision Making in Drug Development
• Flexible and Efficient Data Management and Statistical Analysis
• Model-Driven Combined Design in Phase I/II Clinical Trials
 
On behalf of the committee, we sincerely hope primary discussions, topics and invitees would come across your scientific and strategic interests and the whole summit will be consisted of keynote speeches, panel/roundtable discussions, open Q&A sessions, booth and poster exhibition and guided networking sessions for all professionals and management who are working for the Biopharma industry in Asia
 
Who Should Attend?
More than 300 participants are expected to attend 鈥淭he 3rd Asia Pharma R&D Innovation Conference 2019, attracting the strong contingent throughout the Asia Pacific, USA and Europe. To breakdown, the participants will mainly come from:
 
By Attendees:
By Attendees:
Chief Executive Officer
Chief Medical Officer
Chief Scientific Officer
SVP, VP, Head, Director of
 
Research and Development
R&D Business Development
Medical Affairs
Outsourcing and Externalization
Oncology/CNS/Diabetes Research
Biomarker and Translational Research
Licensing and Partnership
Clinical Trials
 
By Industry:
Animal Studies Services
Bioparks
Pharma/Biopharmas
Biotechs
Clinical Data Management
Clinical Research / Clinical Trials Services
Cold Chain Solutions
Compliance and Validation Services
Contract Research Services
Database / Data Mining
Drug Discovery Support Software
Electronic Data Capturing Systems
Genomic Research Tools and Equipments
High Performance Computing
Imaging Systems/Image Analysis
Legal Companies
Mass Spectrometry Analysis
Microarray Instruments
Private Equity
Proteomics Research Tools and Reagents
Protein/DNA Analyzing Software
Research Equipment and Consumables
Recruitment Agencies
Stem Cell Research Technologies
Technology Transfer/Licensing Services
Venture Capital Firms
 
Why you can not miss Asia Pharma R&D Innovation 2019?
1.Develop new business models in 2019 and beyond for pharma R&D geared toward cost efficiency and ROI improvement
2.Navigate Asia market trends for heavily invested therapeutics areas: oncology, CNS and metabolic diseases
3.Lay foundations for effective partnership with top China CRO,biotech and academia
4.Hear how government initiatives in China 13th 5 years鈥 plan benefit for your research projects in China
5.Learn from best practice in managing research, balancing costs, risk and profits
6.Explore mass in-licensing opportunities in Asia emerging markets in response to new world R&D order
7.Meet 1 on 1 with your end buyers who plan to outsource R&D to Asia for their R&D in Europe or US
8.Build right contacts in big pharma for your early stage discoveries and identify how deals can be done in Asia
9.Identify late stage opportunities in Asia to gain competitiveness when facing patent cliff in 2019
 
Contact Person:Marketing Department
Direct Line:86 21 31602153
Related News>> more
advertisement
Copyright(C) 2006-2019 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙